VI
RMD icon

Versor Investments’s ResMed RMD Stock Holding History

Versor Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,220
Closed -$573K – 872
2025
Q2 		$573K Buy
2,220
+418
+23% +$99.7K 0.1% 341
2025
Q1 		$403K Sell
1,802
-5,558
-76% -$1.3M 0.07% 479
2024
Q4 		$1.68M Buy
7,360
+5,060
+220% +$1.22M 0.29% 52
2024
Q3 		$561K Sell
2,300
-2,400
-51% -$536K 0.09% 378
2024
Q2 		$900K Buy
4,700
+3,600
+327% +$730K 0.17% 176
2024
Q1 		$218K Buy
+1,100
New +$202K 0.04% 598
2019
Q1 		– Sell
-5,400
Closed -$615K – 322
2018
Q4 		$615K Buy
+5,400
New +$579K 0.14% 135
2017
Q2 		– Sell
-3,544
Closed -$255K – 200
2017
Q1 		$255K Buy
+3,544
New +$245K 0.1% 73

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Versor Investments's RMD Position: Q3 2025 in Review

Versor Investments sold out of ResMed (RMD) in Q3 2025, closing a stake of 2,220 shares — an estimated $573K sold.

Versor Investments first reported a position in RMD in Q1 2017 and held it in 8 quarters. The position peaked at $1.68M in Q4 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Versor Investments reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Versor Investments sold 2,220 ResMed shares in Q3 2025, an estimated $573K.
  • Versor Investments first reported a position in ResMed in Q1 2017 and held it in 8 quarters.
  • Versor Investments's ResMed position peaked at $1.68M in Q4 2024.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.